Home > Insider Trading > Filing (0000950170-23-068812)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1816736	Disc Medicine Inc.	IRON	Pharmaceutical Preparations (2834)	851613057

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1951845	Joanne Bryce	C/O Disc Medicine, Inc. 321 Arsenal Street, Suite 101 Watertown MA 02472	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-12-05	526	$1.01	4,286	No	4	M	Direct
Common Stock	Acquisiton	2023-12-05	755	$1.01	5,041	No	4	M	Direct
Common Stock	Disposition	2023-12-05	1,148	$55.29	3,893	No	4	S	Direct
Common Stock	Disposition	2023-12-05	1,293	$56.55	2,600	No	4	S	Direct
Common Stock	Disposition	2023-12-05	100	$57.06	2,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-12-05	526	$0.00	526	$1.01
Common Stock	Stock Option (Right to Buy)	Disposition	2023-12-05	755	$0.00	755	$1.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2029-11-05	No	4	M	Direct
752		2029-11-05	No	4	M	Direct

Footnotes

The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.93 to $55.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.05 to $57.04, inclusive.
The shares underlying this option are fully vested and exercisable as of the date hereof.
The shares underlying this option vest in 16 equal quarterly installments following May 1, 2020, subject to the Reporting Person's continued service on each such vesting date.